• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜病理学作为认知障碍和阿尔茨海默病的生物标志物。

Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease.

机构信息

Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

出版信息

J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):917-22. doi: 10.1136/jnnp-2011-301628. Epub 2012 Jun 25.

DOI:10.1136/jnnp-2011-301628
PMID:22733082
Abstract

Alzheimer's disease (AD) is the most common cause of dementia. Furthermore, over the last few decades, there has been a shift towards identifying earlier stages of AD, which include mild cognitive impairment (MCI). Improved methods of screening and early detection are essential to identify cognitively normal individuals who have a high risk of developing MCI and AD, so that interventions can be developed to delay the progression of specific disease-related pathologies. Thus far, novel biomarkers that have been examined include structural and functional neuroimaging as well as biochemical analysis of cerebrospinal fluid. However, in spite of these efforts, there is still an urgent need for unravelling additional novel biomarkers for AD and MCI. As the retina shares many features with the brain, including embryological origin, anatomical (such as microvascular bed) and physiological characteristics (such as blood-tissue barrier), it has been suggested that the retina may provide an easily accessible and non-invasive way of examining pathology in the brain. While most AD-related pathology occurs in the brain, the disease has also been reported to affect different regions of the retina, including the macular region and optic disc. Studies have suggested that retinal pathology, such as deposits in the macular region, decreased retinal nerve fibre thickness, and optic disc cupping and retinal microvascular abnormalities may be related to AD and cognitive impairment. This article presents a review of current literature on retinal involvement in AD and MCI.

摘要

阿尔茨海默病(AD)是痴呆症最常见的病因。此外,在过去几十年中,人们已经转向识别 AD 的早期阶段,包括轻度认知障碍(MCI)。改进的筛选和早期检测方法对于识别认知正常但有发生 MCI 和 AD 高风险的个体至关重要,以便可以开发干预措施来延缓特定疾病相关病理学的进展。到目前为止,已经检查了包括结构和功能神经影像学以及脑脊液生化分析在内的新型生物标志物。然而,尽管进行了这些努力,但仍然迫切需要发现 AD 和 MCI 的其他新型生物标志物。由于视网膜与大脑具有许多共同特征,包括胚胎起源、解剖学(如微血管床)和生理学特征(如血液-组织屏障),因此有人认为视网膜可能提供一种易于接近和非侵入性的方法来检查大脑中的病理学。虽然大多数与 AD 相关的病理学发生在大脑中,但也有报道称该疾病还会影响视网膜的不同区域,包括黄斑区和视盘。研究表明,视网膜病理学,如黄斑区的沉积物、视网膜神经纤维厚度减少以及视盘凹陷和视网膜微血管异常,可能与 AD 和认知障碍有关。本文综述了目前关于 AD 和 MCI 中视网膜受累的文献。

相似文献

1
Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease.视网膜病理学作为认知障碍和阿尔茨海默病的生物标志物。
J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):917-22. doi: 10.1136/jnnp-2011-301628. Epub 2012 Jun 25.
2
[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].[美国国立衰老研究所和阿尔茨海默病协会关于阿尔茨海默病诊断指南的2011年新建议:临床前阶段、轻度认知障碍和痴呆症]
Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12.
3
[How far reaches earliness of optical coherence tomography in cognitive impairment].[光学相干断层扫描在认知障碍中的早期诊断作用能达到何种程度]
Rev Neurol. 2016 Jul 1;63(1):5-10.
4
Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer's disease.视网膜成像技术的进展有望成为阿尔茨海默病早期诊断的生物标志物。
Transl Neurodegener. 2021 Feb 1;10(1):6. doi: 10.1186/s40035-021-00230-9.
5
Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.轻度认知障碍和阿尔茨海默病型痴呆患者的脑脊液皮质醇与临床疾病进展
Neurobiol Aging. 2015 Feb;36(2):601-7. doi: 10.1016/j.neurobiolaging.2014.10.031. Epub 2014 Oct 31.
6
Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.阿尔茨海默病和轻度认知障碍的视网膜生物标志物:系统评价和荟萃分析。
Ageing Res Rev. 2021 Aug;69:101361. doi: 10.1016/j.arr.2021.101361. Epub 2021 May 14.
7
Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.在一个早期富集的轻度认知障碍样本中,用于预测转化和认知衰退的认知标志物和生物标志物的不同强度。
J Alzheimers Dis. 2015;44(2):625-33. doi: 10.3233/JAD-141716.
8
Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment.基于多模态稀疏表示的阿尔茨海默病和轻度认知障碍分类。
Comput Methods Programs Biomed. 2015 Nov;122(2):182-90. doi: 10.1016/j.cmpb.2015.08.004. Epub 2015 Aug 10.
9
Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease.脑谷胱甘肽水平——轻度认知障碍和阿尔茨海默病的新型生物标志物。
Biol Psychiatry. 2015 Nov 15;78(10):702-10. doi: 10.1016/j.biopsych.2015.04.005. Epub 2015 Apr 14.
10
T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.T1rho磁共振成像与脑脊液生物标志物在阿尔茨海默病诊断中的应用
Neuroimage Clin. 2015 Feb 26;7:598-604. doi: 10.1016/j.nicl.2015.02.016. eCollection 2015.

引用本文的文献

1
Cerebral Amyloid Deposition With F-Florbetapir PET Mediates Retinal Vascular Density and Cognitive Impairment in Alzheimer's Disease.F-氟比他吡PET检测的脑淀粉样蛋白沉积介导阿尔茨海默病患者的视网膜血管密度及认知障碍
Hum Brain Mapp. 2025 Aug 1;46(11):e70310. doi: 10.1002/hbm.70310.
2
Oculomic stratification of COVID-19 patients' intensive therapy unit admission status and mortality by retinal morphological findings.基于视网膜形态学发现对 COVID-19 患者重症监护病房入院状态和死亡率的眼分析分层。
Sci Rep. 2024 Sep 12;14(1):21312. doi: 10.1038/s41598-024-68543-z.
3
Are Hyperglycemia-Induced Changes in the Retina Associated with Diabetes-Correlated Changes in the Brain? A Review from Zebrafish and Rodent Type 2 Diabetes Models.
高血糖诱导的视网膜变化与糖尿病相关的脑变化有关吗?来自斑马鱼和啮齿动物2型糖尿病模型的综述。
Biology (Basel). 2024 Jun 27;13(7):477. doi: 10.3390/biology13070477.
4
Time dependent effects of prolonged hyperglycemia in zebrafish brain and retina.长期高血糖对斑马鱼大脑和视网膜的时间依赖性影响。
Front Ophthalmol (Lausanne). 2022 Aug 25;2:947571. doi: 10.3389/fopht.2022.947571. eCollection 2022.
5
Risk of Alzheimer's Disease and Related Dementias in Persons with Glaucoma: A National Cohort Study.青光眼患者罹患阿尔茨海默病及相关痴呆症的风险:一项全国性队列研究。
Ophthalmology. 2024 Mar;131(3):302-309. doi: 10.1016/j.ophtha.2023.10.014. Epub 2023 Oct 13.
6
Development of a three-dimensional organoid model to explore early retinal phenotypes associated with Alzheimer's disease.开发一种三维类器官模型,以探索与阿尔茨海默病相关的早期视网膜表型。
Sci Rep. 2023 Aug 24;13(1):13827. doi: 10.1038/s41598-023-40382-4.
7
Assessing the Sensitivity of OCT-A Retinal Vasculature Metrics.评估 OCT-A 视网膜血管测量指标的敏感性。
Transl Vis Sci Technol. 2023 Aug 1;12(8):2. doi: 10.1167/tvst.12.8.2.
8
Visual and cognitive functioning among older adults with low vision before vision rehabilitation: A pilot study.视力康复前低视力老年人的视觉和认知功能:一项试点研究。
Front Psychol. 2023 Mar 22;14:1058951. doi: 10.3389/fpsyg.2023.1058951. eCollection 2023.
9
Associations Between Thinner Retinal Neuronal Layers and Suboptimal Brain Structural Integrity in a Middle-Aged Cohort.中年人群中较薄的视网膜神经层与欠佳的脑结构完整性之间的关联
Eye Brain. 2023 Mar 11;15:25-35. doi: 10.2147/EB.S402510. eCollection 2023.
10
Sensory Loss and Risk of Dementia.感觉丧失与痴呆风险
Neuroscientist. 2024 Apr;30(2):247-259. doi: 10.1177/10738584221126090. Epub 2022 Sep 28.